In summary, the use of partial liquid ventilation with perfluorocarbon seems to be safe in neonates, children, and adults with ALI or ARDS. Partial liquid ventilation can be used for the following goals: recruitment of lung volume; enhancement or uniformity of lung inflation; improved oxygenation; improved lung compliance; and prevention or minimization of lung damage induced by mechanical ventilation. Partial liquid ventilation improved gas exchange and lung mechanics in test subjects. Cardiopulmonary interaction and long-term safety require further study. Extrapolations from animal data, however, suggest that there are no long-term undesired effects. The current clinical data strongly suggest that close monitoring and adjustment of ventilator parameters during drug instillation are necessary to reduce hypoxia, bradycardia, and pneumothorax. Further studies are required to explore the efficacy of partial liquid ventilation with perfluorocarbon in ALI or ARDS subjects, in particular, to evaluate the safety and efficacy of smaller doses; mechanical ventilation strategies; and outcomes. Additional research including large randomized studies is clearly required to answer these and other questions.
|Original language||English (US)|
|Number of pages||16|
|Journal||Respiratory care clinics of North America|
|State||Published - Dec 1998|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine